Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Development of an Enhanced Sensitivity Bead-Based Immunoassay for Real-Time In Vivo Detection of Pancreatic β-Cell Death.

Costa OR, Stangé G, Verhaeghen K, Brackeva B, Nonneman E, Hampe CS, Ling Z, Pipeleers D, Gorus FK, Martens GA.

Endocrinology. 2015 Dec;156(12):4755-60. doi: 10.1210/en.2015-1636. Epub 2015 Oct 2.

2.

Quantitative proteomics of rat and human pancreatic beta cells.

Brackeva B, Kramer G, Vissers JP, Martens GA.

Data Brief. 2015 Mar 10;3:234-9. doi: 10.1016/j.dib.2015.02.019. eCollection 2015 Jun.

3.

Potential of UCHL1 as biomarker for destruction of pancreatic beta cells.

Brackeva B, De Punt V, Kramer G, Costa O, Verhaeghen K, Stangé G, Sadones J, Xavier C, Aerts JM, Gorus FK, Martens GA.

J Proteomics. 2015 Mar 18;117:156-67. doi: 10.1016/j.jprot.2015.01.009. Epub 2015 Jan 29.

PMID:
25638021
4.

Potential of protein phosphatase inhibitor 1 as biomarker of pancreatic β-cell injury in vitro and in vivo.

Jiang L, Brackeva B, Ling Z, Kramer G, Aerts JM, Schuit F, Keymeulen B, Pipeleers D, Gorus F, Martens GA.

Diabetes. 2013 Aug;62(8):2683-8. doi: 10.2337/db12-1507. Epub 2013 Apr 4.

5.

LC-MS/MS identification of doublecortin as abundant beta cell-selective protein discharged by damaged beta cells in vitro.

Jiang L, Brackeva B, Stangé G, Verhaeghen K, Costa O, Couillard-Després S, Rotheneichner P, Aigner L, Van Schravendijk C, Pipeleers D, Ling Z, Gorus F, Martens GA.

J Proteomics. 2013 Mar 27;80:268-80. doi: 10.1016/j.jprot.2012.12.031. Epub 2013 Jan 19.

PMID:
23337804

Supplemental Content

Loading ...
Support Center